U.S. Life Sciences Stock News

Century Therapeutics (IPSC) just posted FY 2025 results that put revenue at US$109.2 million with basic EPS of US$0.51 for the latest half, against a trailing twelve month profile that still shows a loss, with EPS of US$0.11 and net income of US$9.6 million in the red on US$109.2 million of revenue. Over the past year, the company has reported revenue of US$1.6 million and EPS of US$0.82 in early 2024, then US$4.96 million with EPS of US$0.79 in the second half of 2024, and then the latest...

ProFrac Holding (ACDC) closed out FY 2025 with fourth quarter revenue of US$436.5 million and a basic EPS loss of US$0.79, alongside net income excluding extra items of a US$142.6 million loss. Over the past few quarters, the company has seen revenue move from US$600.3 million and a basic EPS loss of US$0.12 in Q1 2025 to US$403.1 million and a basic EPS loss of US$0.60 in Q3 2025. Trailing twelve month figures show revenue at US$1.9 billion and a net loss of US$369 million, setting up a...

CareCloud (CCLD) has capped FY 2025 with fourth quarter revenue of US$34.4 million and basic EPS of US$0.04, alongside trailing 12 month revenue of US$120.5 million and basic EPS of US$0.10, marking a clean move away from the losses seen earlier in the period. The company has seen quarterly revenue step up from US$27.4 million in Q2 2025 to US$34.4 million in Q4 2025, while quarterly basic EPS has shifted from a loss of US$0.04 in Q1 2025 to positive readings in each subsequent quarter,...

Trinity Capital (NasdaqGS:TRIN) has recently committed growth capital to three MedTech companies: Monteris Medical, Emboline, and Neuros Medical. The financing supports commercialization of Monteris Medical's neurosurgical system, Emboline's heart procedure protection platform, and Neuros Medical's non opioid pain treatment device. These back to back commitments expand Trinity Capital's exposure to advanced medical technologies within its venture lending portfolio. Trinity Capital focuses...

Voyager Therapeutics, Inc. recently reported fourth-quarter 2025 results showing a net loss of US$27.43 million, improving from US$34.49 million a year earlier, while its full-year 2025 net loss widened to US$119.72 million from US$65.00 million in 2024. Although Voyager reduced its quarterly loss per share, the much larger full-year loss highlights the cost intensity of advancing its neurological disease pipeline. We’ll now examine how Voyager’s improved quarterly loss but much larger...

Zurn Elkay Water Solutions (NYSE:ZWS) reported record annual performance with double digit core sales growth. The company highlighted improved operating margins over the year. Management announced a substantial increase in its dividend. The company also disclosed a significant share repurchase program. Zurn Elkay Water Solutions focuses on water management products and systems, an area that sits at the intersection of infrastructure, building construction, and resource efficiency. With...

Montauk Renewables (MNTK) closed out FY 2025 with Q4 revenue of US$43.4 million and basic EPS of US$0.02 on net income of US$2.5 million, setting the tone for a year where reported earnings and margins were under close watch. The company has seen quarterly revenue move from US$27.7 million and basic EPS of US$0.06 in Q4 2024 to a mix of losses and profits through 2025, including Q2 revenue of US$45.1 million with a loss of US$5.5 million and basic EPS of US$0.04, before landing on US$45.3...

Velocity Financial FY 2025 results in focus Velocity Financial (VEL) has wrapped up FY 2025 with fourth quarter total revenue of US$57.1 million and basic EPS of US$0.89, setting the tone for how investors will read the full year. The company has seen quarterly revenue move from US$84.9 million in Q4 2024 to US$57.1 million in Q4 2025, while basic EPS shifted from US$0.62 to US$0.89 over the same period, and on a trailing twelve month basis EPS stands at US$2.81 on revenue of US$183.5...

Sleep Number (SNBR) has capped FY 2025 with fourth quarter revenue of US$347.4 million and a basic EPS loss of US$2.55, as net income excluding extra items came in at a loss of US$58.5 million. The company has seen quarterly revenue move from US$393.3 million in Q1 2025 to US$327.9 million in Q2, US$342.9 million in Q3 and US$347.4 million in Q4, alongside a widening basic EPS loss over the same stretch. For investors, that mix of steady sales levels and deeper losses keeps the focus firmly...

Q32 Bio (QTTB) has just posted its FY 2025 numbers, reporting fourth quarter revenue of US$53.7 million and basic EPS of US$4.60, alongside trailing 12 month basic EPS of US$2.42 and net income of US$29.8 million. The company’s quarterly revenue has moved from US$0 and a basic EPS loss of US$1.16 in Q4 2024 to US$53.7 million and US$4.60 in Q4 2025. Interim 2025 quarters showed no revenue and basic EPS losses between US$0.60 and US$0.90, so investors will likely focus on how durable these...

Aemetis (AMTX) has wrapped up FY 2025 with Q4 revenue of US$53.7 million and a basic EPS loss of US$0.08, alongside trailing 12 month revenue of US$197.6 million and a cumulative net loss of US$77.0 million. Over recent quarters, the company has seen quarterly revenue move between US$42.9 million and US$59.2 million, while basic EPS losses ranged from US$0.47 to US$0.08. This latest print keeps the focus squarely on how quickly margins can tighten up from here. See our full analysis for...

Chicago Atlantic Real Estate Finance (REFI) has wrapped up FY 2025 with fourth quarter total revenue of US$14.1 million and basic EPS of US$0.39, giving investors fresh numbers to weigh against its high headline yield and recent margin trends. The company has seen quarterly revenue move between US$13.1 million and US$15.4 million over the last six reported periods, while basic EPS ranged from US$0.39 to US$0.57 over the same timeframe. This sets a clear frame of reference for the latest print...

LifeMD (LFMD) is back in focus after its latest earnings, where the telehealth provider reported full year 2025 net income of US$14.35 million and issued fresh 2026 revenue guidance. See our latest analysis for LifeMD. LifeMD’s latest earnings and 2026 guidance have arrived after a sharp recent move, with a 7 day share price return of 31.17% and a 30 day share price return of 29.02% despite a 1 year total shareholder return decline of 30.48%. Short term momentum is building, while the longer...

Bumble (BMBL) has returned to investor attention after Q4 2025 earnings topped expectations, first quarter 2026 revenue guidance of US$209 million to US$213 million, and the announcement of new AI driven product and platform plans. See our latest analysis for Bumble. The Q4 surprise and AI rollout have triggered a sharp shift in sentiment, with a 34.2% 1-day share price return and 21.7% 7-day share price return contrasting with a 1-year total shareholder return of negative 20%. This suggests...

Latest FY 2025 results set the stage Navigator Holdings (NVGS) has capped FY 2025 with fourth quarter revenue of US$152.8 million and basic EPS of US$0.28, while the trailing twelve month figures show revenue of US$587.0 million and EPS of US$1.49, supported by net income of US$100.1 million. Over the past few individual quarters, revenue has ranged from US$129.6 million to just over US$153.1 million. Quarterly EPS has moved between US$0.26 and US$0.50, and investors will likely focus on how...

Codexis FY 2025 Results: Revenue Rebounds As Profitability Swings Positive In Q4 Codexis (CDXS) closed FY 2025 with a sharp Q4 reset, reporting US$38.9 million in revenue and basic EPS of US$0.11, alongside net income of US$9.6 million, against a trailing twelve month loss of US$44.0 million and a TTM basic EPS loss of US$0.50. The company has seen quarterly revenue move from US$21.5 million in Q4 2024 to US$7.5 million in Q1 2025, US$15.3 million in Q2 2025, US$8.6 million in Q3 2025, and...

Guardian Pharmacy Services (GRDN) has just wrapped up FY 2025 with Q4 revenue of US$397.6 million and basic EPS of US$0.33, alongside trailing 12 month revenue of about US$1.4 billion and EPS of US$0.79 as the business has moved into consistent profitability. The company has seen revenue lift from US$338.6 million and EPS of a US$0.17 loss in Q4 FY 2024 to US$397.6 million and EPS of US$0.33 in Q4 FY 2025, while trailing net income shifted from a US$110.0 million loss at FY 2024 year end to a...

Resolute Holdings Management (RHLD) has put out a mixed set of FY 2025 numbers, with Q3 revenue at US$120.9 million and a small net loss of US$0.2 million, translating to basic EPS of US$0.03 loss per share. Over recent quarters the company has seen revenue move from US$103.9 million in Q1 FY 2025 to US$119.6 million in Q2 and US$120.9 million in Q3. EPS shifted from a US$0.39 loss to a US$0.07 loss and then to a US$0.03 loss, setting the backdrop for investors who are watching how much of...

Stoneridge (SRI) has just reported third quarter FY 2025 results with revenue of US$210.3 million and a basic EPS loss of US$0.34, while net income excluding extra items was a loss of US$9.4 million. Over recent quarters, the company has seen revenue move between US$213.8 million and US$237.1 million with basic EPS ranging from a profit of US$0.10 to losses of roughly US$0.22 to US$0.34. The trailing twelve month figures show US$874.4 million of revenue paired with a net loss of US$32.0...

Kansas City Life Insurance (KCLI) has wrapped up FY 2025 with fourth quarter revenue of US$120.4 million, basic EPS of US$0.23 and net income of US$2.3 million, alongside trailing 12 month revenue of US$485.5 million and a net loss of US$20.8 million, which translates to basic EPS of a US$2.14 loss. Over recent quarters the company has seen revenue move between US$118.98 million and US$125.15 million, while quarterly EPS has ranged from a US$2.90 loss to a US$0.33 profit. This sets up a story...

Inland Real Estate Income Trust (INRE) has posted its FY 2025 numbers with Q4 total revenue of US$38.7 million and a basic EPS loss of US$0.12, alongside funds from operations of US$36.3 million in the red. This gives investors a mixed read on operating performance and cash generation. Over the past year, total revenue has held in a tight band around US$150 million on a trailing twelve month basis while basic EPS for the same period came in at a loss of US$0.31, underscoring a sustained loss...

Mistras Group (MG) just closed out FY 2025 with fourth quarter revenue of US$181.5 million and basic EPS of US$0.12, alongside trailing twelve month revenue of US$724.0 million and EPS of US$0.54 that were shaped by a reported net profit margin of 2.3%. Over recent periods, the company has seen quarterly revenue move from US$172.7 million in FY 2024 Q4 to US$195.5 million in FY 2025 Q3 before landing at US$181.5 million in FY 2025 Q4. Quarterly EPS ranged from a loss of US$0.10 in FY 2025 Q1...

TechTarget (TTGT) has just posted its FY 2025 numbers with Q4 revenue of US$140.7 million and a basic EPS loss of US$0.13, capping a trailing 12 month period that featured revenue of US$486.8 million and a basic EPS loss of US$14.06. Over recent quarters, the company has seen revenue move from US$99.9 million in Q4 FY 2024 to US$103.9 million in Q1 FY 2025, US$119.9 million in Q2, US$122.3 million in Q3 and US$140.7 million in Q4. Quarterly basic EPS losses shifted from US$0.90 to US$7.32,...

Sealed Air (NYSE:SEE) has announced its intention to redeem multiple senior notes, subject to the closing of a pending transaction. The planned redemptions would retire certain outstanding debt instruments once the transaction is completed. The company has outlined the expected redemption terms ahead of closing to give bondholders and shareholders clarity on next steps. For investors watching Sealed Air, the focus now is on how this conditional redemption plan fits with the company’s...